Valgen Medtech Recognized as "Zhejiang Unicorn Enterprise" for 2026

HANGZHOU, April 23, 2026 — Valgen Medtech was once again honored as both a "Zhejiang Provincial Unicorn Enterprise" and a "Hangzhou Municipal Unicorn Enterprise."

As a leading innovator in atrioventricular valve intervention, Valgen Medtech has received this distinction for several consecutive years. This recognition underscores the company’s strong R&D capabilities and its long-term professional commitment to the structural heart field.

Moving forward, Valgen Medtech will continue to leverage its expertise to drive the high-quality development of interventional cardiology, delivering advanced solutions like the DragonFly™ System to patients worldwide.